Dr. Bret Alan Cook, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1900 Woodland Dr, Coos Bay, OR 97420 Phone: 541-267-5151 Fax: 541-267-3800 |
Dr. Unknown Cherry, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1900 Woodland Dr, Coos Bay, OR 97420 Phone: 541-267-5151 Fax: 541-267-3800 |
Anushi Bulumulle, M.D Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1775 Thompson Rd, Coos Bay, OR 97420 Phone: 541-269-8111 |
News Archive
The New York Times: "One of every seven Medicare beneficiaries who is hospitalized is harmed as a result of problems with the medical care there, according to a new study [.pdf] from the Office of Inspector General for the Department of Health and Human Services. The study said unexpected adverse events added at least $4.4 billion a year to government health costs and contributed to the deaths of about 180,000 patients a year."
The gradual accumulation of cell damage plays a very important role in the origin of ageing. There are many sources of cellular damage, however, which ones are really responsible for ageing and which ones are inconsequential for ageing is a question that still lacks an answer
It's August, Congress and the president are on vacation. Nonetheless, talk on the Sunday morning programs looked ahead to the future deficit negotiations by the "super committee" and the president's upcoming economics speech.
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston Clinical Research Institute, an Academic Research Organisation based in Boston, Massachusetts.
Prostate-specific membrane antigen (PSMA) is a surface protein that is normally present on healthy prostate cells, but is found at much higher levels on prostate cancer cells. It is barely found in the rest of the body. "Therefore, PSMA is an ideal target for diagnostic purposes as well as targeted therapies against prostate cancer," says biotechnologist Dr. Matthias Eder of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ).
› Verified 4 days ago